By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Stemedica Cell Technologies, Inc. 

5375 Mira Sorrento Place
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-658-0910 Fax: 858-658-0986


SEARCH JOBS


Industry
Suppliers






Company News
Stemedica Cell Technologies, Inc. Earns U.S. Patent For Cellular Scaffold Enhanced By Stem Cell Factors 6/10/2014 9:40:46 AM
Indonesia’s BPOM Grants IND Approval For SCI To Conduct A Phase 2 Clinical Trial Using Stemedica Cell Technologies, Inc.’s Mesenchymal Stem Cells To Treat Acute Myocardial Infarction 5/27/2014 10:58:54 AM
President Of Leading South Korean Biopharmaceutical Company Green Cross Joins Stemedica Cell Technologies, Inc.'s Board Of Directors 4/22/2014 2:35:58 PM
Stemedica Cell Technologies, Inc. Appoints National Institutes of Health (NIH) Center For Regenerative Medicine Founding Director Dr. Mahendra Rao To Its Scientific And Medical Advisory Board 4/9/2014 6:27:51 AM
Stemedica Cell Technologies, Inc. Appoints National Institutes of Health (NIH) Center For Regenerative Medicine Founding Director Dr. Mahendra Rao To Its Scientific And Medical Advisory Board 4/8/2014 2:30:53 PM
World Stem Cell Summit Poster Forum Prizes Sponsored by Stemedica Cell Technologies, Inc. 10/10/2013 9:23:43 AM
Stemedica Cell Technologies, Inc. Ischemic Tolerant Stem Cells Produce Significant Improvement in Cardiac Function After Heart Attack 4/3/2012 10:12:22 AM
Stemedica Cell Technologies, Inc. Treats First Patient with Ischemic Allogeneic Mesenchymal Stem Cells 3/24/2011 10:44:45 AM
Stemedica Cell Technologies, Inc. Receives Approval From University of California, San Diego (UCSD) to Initiate Ischemic Stroke Study With Adult Allogeneic Stem Cells 2/17/2011 6:21:18 AM
FDA Approves Stemedica Cell Technologies, Inc. IND for Ischemic Stroke Clinical Trial 4/21/2010 8:36:45 AM
123
//-->